Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Carrillo Sepulveda, Maria Alicia ^a,b   Keen, Henry L ^a   Davis, Deborah R ^a   Grobe, Justin L ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTERIAL PRESSURE; C57BL MOUSE; DRUG EFFECTS; HUMAN; HYPERTENSION; METABOLISM; MOUSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; ARTERIAL PRESSURE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; HYPERTENSION; LOSARTAN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PPAR GAMMA; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 84905989058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103786     Document Type: Article

References (40)

1. Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, et al. (2013) PPARγ signaling and metabolism: the good, the bad and the future. Nat Med 19: 557-566.
2. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, et al. (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366: 1279-1289. (Pubitemid 41416583)
3. Sigmund CD (2010) Endothelial and vascular muscle PPARγ in arterial pressure regulation: lessons from genetic interference and deficiency. Hypertension 55: 437-444.
4. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, et al. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402: 880-883.
5. Caron-Debarle M, Auclair M, Vigouroux C, Boccara F, Capel E, et al. (2013) PPARG mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system. Arterioscler Thromb Vasc Biol 33: 829-838.
6. Tsai YS, Kim HJ, Takahashi N, Kim HS, Hagaman JR, et al. (2004) Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. J Clin Invest 114: 240-249. (Pubitemid 39071629)
7. Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, et al. (2008) Interference with PPAR c Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling. Hypertension 51: 867-871. (Pubitemid 351654697)
8. Gray SL, Nora ED, Grosse J, Manieri M, Stoeger T, et al. (2006) Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARγ) in mice. Diabetes 55: 2669-2677. (Pubitemid 44923664)
9. Nicol CJ, Adachi M, Akiyama TE, Gonzalez FJ (2005) PPARγ in endothelial cells influences high fat diet-induced hypertension. Am J Hypertens 18: 549-556.
10. Kleinhenz JM, Kleinhenz DJ, You S, Ritzenthaler JD, Hansen JM, et al. (2009) Disruption of endothelial peroxisome proliferator-activated receptor gamma (PPARγ) reduces vascular nitric oxide production. Am J Physiol Heart Circ Physiol 297: H1647-H1654.
11. Kanda T, Brown JD, Orasanu G, Vogel S, Gonzalez FJ, et al. (2009) PPARγ in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest 119: 110-124.
12. Subramanian V, Golledge J, Ijaz T, Bruemmer D, Daugherty A (2010) Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cellspecific interaction with PPARγ. Circ Res 107: 953-958.
13. Marchesi C, Rehman A, Rautureau Y, Kasal DA, Briet M, et al. (2013) Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Cardiovasc Res 97: 562-570.
14. Beyer AM, de Lange WJ, Halabi CM, Modrick ML, Keen HL, et al. (2008) Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet. Circ Res 103: 654-661.
15. Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, et al. (2008) Interference with PPARγ Function in Smooth Muscle Causes Vascular Dysfunction and Hypertension. Cell Metabolism 7: 215-226. (Pubitemid 351285526)
16. Ketsawatsomkron P, Lorca RA, Keen HL, Weatherford ET, Liu X, et al. (2012) PPARγ Regulates Resistance Vessel Tone Through a Mechanism Involving RGS5-Mediated Control of PKC and BKCa Channel Activity. Circ Res 111: 1446-1458.
17. Pelham CJ, Ketsawatsomkron P, Groh S, Grobe JL, de Lange WJ, et al. (2012) Cullin-3 Regulates Vascular Smooth Muscle Function and Arterial Blood Pressure via PPARγ and RhoA/Rho-Kinase. Cell Metab 16: 462-472.
18. Keen HL, Ryan MJ, Beyer A, Mathur S, Scheetz TE, et al. (2004) Gene expression profiling of potential PPARγ target genes in mouse aorta. Physiological Genomics 18: 33-42. (Pubitemid 39319484)
19. Keen HL, Halabi CM, Beyer AM, de Lange WJ, Liu X, et al. (2010) Bioinformatic analysis of gene sets regulated by ligand-activated and dominantnegative peroxisome proliferator-activated receptor gamma in mouse aorta. Arterioscler Thromb Vasc Biol 30: 518-525.
20. Carrillo-Sepulveda MA, Ceravolo GS, Fortes ZB, Carvalho MH, Tostes RC, et al. (2010) Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. Cardiovasc Res 85: 560-570.
21. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, et al. (2010) The Brain Renin-Angiotensin System Controls Divergent Efferent Mechanisms to Regulate Fluid and Energy Balance. Cell Metabolism 12: 431-442.
22. Hilzendeger AM, Cassell MD, Davis DR, Stauss HM, Mark AL, et al. (2013) Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension. Hypertension 61: 716-722.
23. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, et al. (2002) Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation 105: 2296-2302. (Pubitemid 34535341)
24. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD (2004) PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 43: 661-666. (Pubitemid 38282444)
25. Sigmund CD (2013) A clinical link between peroxisome proliferator- activated receptor gamma and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 33: 676-678.
26. Yang HM, Kim BK, Kim JY, Kwon YW, Jin S, et al. (2013) PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury. Exp Mol Med 45: e65.
27. Zhang L, Xie P, Wang J, Yang Q, Fang C, et al. (2010) Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension. J Biol Chem 285: 13666-13677.
28. Meredith D, Panchatcharam M, Miriyala S, Tsai YS, Morris AJ, et al. (2009) Dominant-negative loss of PPARγ function enhances smooth muscle cell proliferation, migration, and vascular remodeling. Arterioscler Thromb Vasc Biol 29: 465-471.
29. Nguyen Dinh CA, Montezano AC, Burger D, Touyz RM (2013) Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal 19: 1110-1120.
30. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148. (Pubitemid 24176909)
31. Nisbet RE, Bland JM, Kleinhenz DJ, Mitchell PO, Walp ER, et al. (2010) Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol 42: 482-490.
32. Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, et al. (2012) The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol 47: 718-726.
33. Blanquicett C, Kang BY, Ritzenthaler JD, Jones DP, Hart CM (2010) Oxidative stress modulates PPAR gamma in vascular endothelial cells. Free Radic Biol Med 48: 1618-1625.
34. Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, et al. (2002) Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 11: 21-30. (Pubitemid 37128718)
35. Pelham CJ, Keen HL, Lentz SR, Sigmund CD (2013) Dominant negative PPAR c promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle. Am J Physiol Regul Integr Comp Physiol 304: R690-R701.
36. Takeda K, Ichiki T, Tokunou T, Funakoshi Y, Iino N, et al. (2000) Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. Circulation 102: 1834-9.
37. Zhao SM, Shen LH, Li HW, Wang L, Chen H, et al. (2008) Down-regulation of the expression of angiotensin II type 1 receptor in neonatal rat cardiac fibroblast by activation of PPARγ signal pathway. Chin J Physiol 51: 357-362.
38. Xiao J, Leung JC, Chan LY, Tang SC, Lai KN (2009) Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. Clin Immunol 132: 266-276.
39. Ji Y, Liu J, Wang Z, Liu N, Gou W (2009) PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. Lab Invest 89: 887-902.
40. Borges GR, Morgan DA, Ketsawatsomkron P., Mickle AD, Thompson AP, et al. (2014) Interference with Peroxisome Proliferator-Activated Receptor-γ in Vascular Smooth Muscle Causes Baroreflex Impairment and Autonomic Dysfunction. Hypertension [Epub ahead of print].